Dye & Durham (TSX:DND) Stock Retracts 21%: Should You Buy Now?

Tech stocks often generate higher returns and outperform the benchmark index.

| More on:

It’s always great to have some quality tech stocks in your portfolio, as they often lead to higher returns and outperform the benchmark index. Also, in the post-COVID-19 world, technology is one sector I believe is likely to play a more significant role in all aspects of our lives and could continue to outperform other industries, thanks to the growing demand for the products and solutions based on new-age technologies like cloud, AI, and analytics.  

While the prospects for the TSX-listed tech companies look bright, tech stocks have witnessed a fair amount of selling in the recent past. Take Dye & Durham (TSX:DND) stock, for instance. 

Dye & Durham, through its cloud-based tech platform, provides critical information to legal and business professionals. Shares of Dye & Durham quadrupled from its IPO price since listing on the Toronto Stock Exchange on July 17, thanks to its robust financial performance over the past several years. However, the temporary closure of several courthouses in Canada amid the pandemic weighed on its recent quarterly performance and, in turn, its stock. 

Shares of Dye & Durham have retracted nearly 21% from its peak. So, should you rush to buy its stock at the current levels?  

Is growth on the horizon? 

While the temporary challenges stemming from the pandemic remained a drag on its financials, Dye & Durham has multiple vectors for growth that are likely to support its business’s future success. One of them is the company’s ability to integrate acquired companies.  

Since 2013, Dye & Durham made 14 acquisitions, which have been crucial to its success. The strength in its base business and these acquisitions has helped the company drive revenues and adjusted EBITDA at a breakneck pace.  

Dye & Durham’s top line (from FY16 to FY19) has grown at a CAGR (compound annual growth rate) of 71%. Meanwhile, its adjusted EBITDA increased at a CAGR of 136% in the same period. Despite challenges in the fourth quarter, its revenues increased by 49% in FY20, which is encouraging.  

Besides acquisitions, Dye & Durham benefits from strong organic growth opportunities. It has a large (+25,000 active customers) and a diverse customer base (no one customer accounts for more than 2% of its revenue) with significant room for further growth. Also, its implementation of a monthly subscription offering and focus on creating a sustainable SaaS revenue stream is likely to support its top line and add stability. 

Dye & Durham’s broad penetration into blue-chip customer base, low customer churn rate (about 2%), and higher average tenure (about 16.6 years) of its top 100 clients suggest that it could continue to post strong financial numbers. 

Final thoughts

The retracement in Dye & Durham stock presents a good buying opportunity for long-term investors. With the easing of lockdown measures and reopening of the courthouses, Dye &Durham’s revenues are expected to return to the growth trajectory in the coming quarter.  

With its resilient business model, large addressable market, accretive M&A pipeline, and experienced leadership team, Dye & Durham stock could generate multi-fold returns for its investors. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »